R&D manager Karin Agerman and CEO Jan Nilsson are interviewed in conjunction with BioStock Live Capital Market Day

Wednesday 29 August a capitalmarket day was arranged in Stockholm with several life sience companies. CombiGene took part with CEO Jan Nilsson and R&D chief Karin Angeman.

You can see their conversation with Biostock analytic Linus Flink Elmfors below:
(Only in swedish)

“This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website”